EurekAlert! --PITTSBURGH, Nov. 10 – In the largest study of its kind, Pittsburgh Compound B, an imaging agent that could facilitate the early diagnosis of Alzheimer’s disease, has been used to identify amyloid deposition in the brains of clinically older adults.